相关实验视频

Updated: Jul 6, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

在患有慢性乙型肝炎的患者中,KLRG1表达的CD8+ T细胞已经耗尽并具有多功能

Li Wang¹, Fangli Liao¹, Liping Yang¹

¹Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

|May 22, 2024

概括

慢性乙肝感染中CD8+T细胞上的杀伤细胞学丁样受体G1 (KLRG1) 显示功能多样性. 尽管有抑制信号,但这些细胞表现出活跃的抗病毒功能,挑战了对T细胞枯竭的传统观点.

科学领域:

免疫学免疫学免疫学
病毒学病毒学
T细胞生物学T细胞生物学

背景情况:

杀手细胞学丁类受体G1 (KLRG1) 通常与慢性疾病中的T细胞疲劳有关.
它在乙型肝炎病毒 (HBV) 感染中的确切功能尚不清楚.

研究的目的:

研究KLRG1+ CD8+ T细胞在慢性HBV感染中的作用和功能.
确定KLRG1表达是否意味着抗病毒T细胞的终端枯竭或功能多样性.

主要方法:

对来自190名慢性乙型肝炎患者的CD8+ T细胞进行分析,以检测疲劳,亡和功能的标记.
分类KLRG1+和KLRG1-CD8+T细胞的转录组分析.
在体外验证KLRG1-E-cadherin通路对HBV复制的影响.

主要成果:

特定于HBV的CD8+T细胞表达了高KLRG1水平和与疲劳相关的标记物 (TOX,EOMES,Helios).
KLRG1+ CD8+ T细胞产生显著的抗病毒细胞因子 (TNF-α,IFN-γ) 和细胞毒性分子 (福林,格兰酶B),表明活性功能.
在KLRG1+细胞中,RNA-seq证实了效应细胞和耗尽的T细胞基因的丰富.
发现KLRG1-E-cadherin结合在体外抑制了病毒特异性T细胞的抗病毒功效.

结论:

慢性HBV感染中的KLRG1+ CD8+ T细胞表现出功能多样性,而不仅仅是末端疲劳.
这些细胞具有活跃的抗病毒能力,尽管表达抑制性受体标记物.
KLRG1-E-cadherin通路可以抑制T细胞介导的抗病毒活性.

更多相关视频

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

相关概念视频

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...